Extended Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome (Extended JAPAN-ACS)

Extended Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome (Extended JAPAN-ACS) - Extended Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome (Extended JAPAN-ACS)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000003166

Enrollment

252

Registered

2010-02-12

Start date

2010-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute coronary syndrome

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who were underwent coronary intravascular ultrasound (IVUS) evaluation both at baseline and the follow up period, and whose IVUS data were analyzable in the JAPAN-ACS study.

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Occurrence of one offollowing events (composite endpoint) 1.Cardiovascular death 2.Non-fatal Myocardial Infarction (MI) 3.Non-fatal Cerebral Infarction (CI)4.Unstable angina requiring urgent hospitalizations	—

Secondary

Measure	Time frame
1.Composite cardiovascular events Occurrence of one of following events Cardiovascular death, Non-fatal MI, Non-fatal CI, Unstable angina requiring hospitalizations, Ischemia-driven coronary revascularization except target lesion revascularization (TLR) 2.Composite coronary heart disease events Occurrence of one of following events Coronary heart disease (CHD) death, Non-fatal MI, Unstable angina requiring urgent hospitalizations, Ischemia-driven coronary revascularization except TLR. 3.Composite cerebrovascular events Occurrence of one of following events Fatal and Non-fatal stroke, Transient ischemic attack (TIA) requiring hospitalizations. 4.Death events Occurrence of each following events All-cause mortality Cardiovascular death Cardiac death CHD death 5.Heart disease events Occurrence of each following events Fatal and Non-fatal MI Non-procedure related MI Procedure related MI Unstable angina requiring urgent hospitalizations Resuscitated cardiac arrest Hospitalization for heart failure PCI or CABG (1)All events of PCI or CABG (a)TLR (b)non-TLR (2)Ischemia-driven PCI or CABG (a)TLR (b)non-TLR 6.Cerebrovascular events Occurrence of each following events Fatal and Non-fatal stroke Fatal and Non-fatal CI (1) Non-procedure related CI (2) Procedure related CI Fatal and Non-fatal cerebral hemorrhage Hospitalization for TIA 7.The other events Occurrence of each following events Operation for or rupture of aortic aneurysm Revascularization for peripheral arterial disease (PAD) Carotid artery stenting (CAS) or carotid endarterectomy (CEA) Aortic dissection Deep vein thrombosis (DVT) or pulmonary thromboembolism (PTE) New occurrence of malignant tumor Operation for aortic stenosis	—

Measure

Time frame

1.Composite cardiovascular events Occurrence of one of following events Cardiovascular death, Non-fatal MI, Non-fatal CI, Unstable angina requiring hospitalizations, Ischemia-driven coronary revascularization except target lesion revascularization (TLR) 2.Composite coronary heart disease events Occurrence of one of following events Coronary heart disease (CHD) death, Non-fatal MI, Unstable angina requiring urgent hospitalizations, Ischemia-driven coronary revascularization except TLR. 3.Composite cerebrovascular events Occurrence of one of following events Fatal and Non-fatal stroke, Transient ischemic attack (TIA) requiring hospitalizations. 4.Death events Occurrence of each following events All-cause mortality Cardiovascular death Cardiac death CHD death 5.Heart disease events Occurrence of each following events Fatal and Non-fatal MI Non-procedure related MI Procedure related MI Unstable angina requiring urgent hospitalizations Resuscitated cardiac arrest Hospitalization for heart failure PCI or CABG (1)All events of PCI or CABG (a)TLR (b)non-TLR (2)Ischemia-driven PCI or CABG (a)TLR (b)non-TLR 6.Cerebrovascular events Occurrence of each following events Fatal and Non-fatal stroke Fatal and Non-fatal CI (1) Non-procedure related CI (2) Procedure related CI Fatal and Non-fatal cerebral hemorrhage Hospitalization for TIA 7.The other events Occurrence of each following events Operation for or rupture of aortic aneurysm Revascularization for peripheral arterial disease (PAD) Carotid artery stenting (CAS) or carotid endarterectomy (CEA) Aortic dissection Deep vein thrombosis (DVT) or pulmonary thromboembolism (PTE) New occurrence of malignant tumor Operation for aortic stenosis

—

Countries

Japan

Contacts

Public ContactYumika Fujino

Cardiovascular Research Promotion Unit Cardiovascular Research Promotion Unit

japan-acs.seiken@midinfo.co.jp075-781-1107

Outcome results